BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11597249)

  • 1. A new synthesis of valienamine.
    Kok SH; Lee CC; Shing TK
    J Org Chem; 2001 Oct; 66(21):7184-90. PubMed ID: 11597249
    [No Abstract]   [Full Text] [Related]  

  • 2. An alternative synthesis of 1,1'-bis-valienamine from D-glucose.
    Shing TK; Cheng HM
    J Org Chem; 2010 May; 75(10):3522-5. PubMed ID: 20392097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel synthesis of natural pseudo-aminosugars, (+)-valienamine and (+)-validamine.
    Tatsuta K; Mukai H; Takahashi M
    J Antibiot (Tokyo); 2000 Apr; 53(4):430-5. PubMed ID: 10866227
    [No Abstract]   [Full Text] [Related]  

  • 4. Enzymatic synthesis of glucoside derivatives of validamine and valienamine.
    Furumoto T; Kameda Y; Matsui K
    Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1871-5. PubMed ID: 1394706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Search for alpha-glucosidase inhibitors: new N-substituted valienamine and conduramine F-1 derivatives.
    Łysek R; Schütz C; Favre S; O'Sullivan AC; Pillonel C; Krülle T; Jung PM; Clotet-Codina I; Esté JA; Vogel P
    Bioorg Med Chem; 2006 Sep; 14(18):6255-82. PubMed ID: 16797996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and α-Glucosidase II inhibitory activity of valienamine pseudodisaccharides relevant to N-glycan biosynthesis.
    Cumpstey I; Ramstadius C; Eszter Borbas K; Alonzi DS; Butters TD
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5219-23. PubMed ID: 21840710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the synthesis of valienamine and 1-epi-valienamine starting from D-glucose or L-sorbose.
    Cumpstey I; Gehrke S; Erfan S; Cribiu R
    Carbohydr Res; 2008 Jul; 343(10-11):1675-92. PubMed ID: 18468588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total asymmetric synthesis of (-)-conduramine B-1 and of its enantiomer. N-Benzyl derivatives of conduramine B-1 are beta-glucosidase inhibitors.
    Łysek R; Schütz C; Vogel P
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3071-5. PubMed ID: 15878273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective synthesis of a 4-⍺-glucoside of valienamine and its X-ray structure in complex with Streptomyces coelicolor GlgE1-V279S.
    Si A; Jayasinghe TD; Thanvi R; Kapil S; Ronning DR; Sucheck SJ
    Sci Rep; 2021 Jun; 11(1):13413. PubMed ID: 34183716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An efficient synthesis of valienamine via ring-closing metathesis.
    Chang YK; Lee BY; Kim DJ; Lee GS; Jeon HB; Kim KS
    J Org Chem; 2005 Apr; 70(8):3299-302. PubMed ID: 15823000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymic synthesis of valienamine glucosides and their antibiotic activity.
    Furumoto T; Yoshioka T; Kamata K; Kameda Y; Matsui K
    J Antibiot (Tokyo); 1991 Mar; 44(3):371-3. PubMed ID: 2026563
    [No Abstract]   [Full Text] [Related]  

  • 12. A new pre-column derivatization for valienamine and beta-valienamine using o-phthalaldehyde to determine the epimeric purity by HPLC and application of this method to monitor enzymatic catalyzed synthesis of beta-valienamine.
    Cui L; Guan XQ; Liu ZM; Fan LY; Li Q; Feng Y
    J Asian Nat Prod Res; 2017 Apr; 19(4):347-357. PubMed ID: 28367638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties and production of valienamine and its related analogues.
    Chen X; Fan Y; Zheng Y; Shen Y
    Chem Rev; 2003 May; 103(5):1955-77. PubMed ID: 12744697
    [No Abstract]   [Full Text] [Related]  

  • 14. N-Substituted valienamines, alpha-glucosidase inhibitors.
    Kameda Y; Asano N; Yoshikawa M; Matsui K; Horii S; Fukase H
    J Antibiot (Tokyo); 1982 Nov; 35(11):1624-6. PubMed ID: 6761330
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis of an alpha-fucosidase inhibitor, 5a-carba-beta-L-fucopyranosylamine, and fucose-type alpha- and beta-DL-valienamine unsaturated derivatives.
    Ogawa S; Watanabe M; Maruyama A; Hisamatsu S
    Bioorg Med Chem Lett; 2002 Mar; 12(5):749-52. PubMed ID: 11858994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valienamine as an alpha-glucosidase inhibitor.
    Kameda Y; Asano N; Yoshikawa M; Matsui K
    J Antibiot (Tokyo); 1980 Dec; 33(12):1575-6. PubMed ID: 6788743
    [No Abstract]   [Full Text] [Related]  

  • 17. Asymmetric stereodivergent strategy towards aminocyclitols.
    Trost BM; Malhotra S
    Chemistry; 2014 Jul; 20(27):8288-92. PubMed ID: 24889256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A flexible strategy based on a C2-symmetric pool of chiral substrates: concise synthesis of (+)-valienamine, key intermediate of (+)- pancratistatin, and conduramines A-1 and E.
    Chang YK; Lo HJ; Yan TH
    Org Lett; 2009 Oct; 11(19):4278-81. PubMed ID: 19711969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RCM approaches toward the diastereoselective synthesis of vicinal trans-diaminocyclitols from L-serine.
    Cong X; Liao QJ; Yao ZJ
    J Org Chem; 2004 Aug; 69(16):5314-21. PubMed ID: 15287776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convenient synthesis and evaluation of glycosidase inhibitory activity of alpha- and beta-galactose-type valienamines, and some N-alkyl derivatives.
    Ogawa S; Sakata Y; Ito N; Watanabe M; Kabayama K; Itoh M; Korenaga T
    Bioorg Med Chem; 2004 Mar; 12(5):995-1002. PubMed ID: 14980612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.